Guidelines for the Topical Treatment of Psoriasis Vulgaris in the Levant and Iraq Area.
Skinmed
; 13(6): 445-53, 2015.
Article
in En
| MEDLINE
| ID: mdl-26861521
ABSTRACT
Psoriasis vulgaris is a common chronic, inflammatory, multisystem disorder that affects approximately 1.5% to 3.4% of the population in the Middle East. The disease has an impact on the quality of life in a significant number of affected patients. The majority of patients (approximately 70%) have mild to moderate psoriasis that is manageable with topical agents, which generally show a high efficacy to safety ratio. Topical agents can be used alone when treating patients with limited disease or may be used as adjunctive therapy for patients with more extensive psoriasis undergoing systemic treatment. Treatment should also be customized to meet individual patients' needs. To optimize the topical treatment of psoriasis in the Levant and Iraq area, dermatology experts from Iraq, Jordan, Lebanon, Palestine, and Syria met and initiated a project to develop guidelines and recommendations for the topical management of psoriasis. The guidelines are based on literature evidence and experts' opinions. We present recommendations for the use of topical corticosteroids, vitamin D analogues, calcineurin inhibitors, tazarotene, salicylic acid, anthralin, and coal tar, as well as combination therapy, based on their efficacy and safety profiles.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Aspects:
Patient_preference
Language:
En
Journal:
Skinmed
Journal subject:
DERMATOLOGIA
Year:
2015
Document type:
Article
Affiliation country: